4-Bromo-2-chloropyridine

We are 4-Bromo-2-chloropyridine CAS:73583-37-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Bromo-2-chloropyridine
CAS.NO:73583-37-6
Synonyms:4-Bromo-2-chloropyridine
Molecular Formula:C5H3BrClN
Molecular Weight:192.44100
 
Physical and Chemical Properties:
Density:1.7336
Melting point:27ºC
Boiling point:70ºC
Flash point:225°F
Index of Refraction:1.5900
 
Specification:
Appearance:Gray-white crystal
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

4-Bromo-2-chloropyridine


Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.2-Fluoro-5-methylpyridine CAS:2369-19-9 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.Ácido 4-pentilbencenoborónico CAS:121219-12-3 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.101987-86-4 The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).

Related Products
Product Name
4-phenylbutan-1-ol View Details
Tripeptide-10 citrulline View Details
2,2′,4,4′-Tetrahydroxybenzophenone View Details
1-(2,3-DICHLOROPHENYL)PIPERAZINE manufacturer 3-(N-Methylpentylamino)Propionic Acid Hydrochloride manufacturer 3-(4-NITROPHENYL)PYRIDINE manufacturer S-methyl thioacetate manufacturer 4′-N-OCTYLACETOPHENONE manufacturer